Median Technologies and CMIC HOLDINGS have signed a collaborative agreement for comprehensive clinical trial services. Together, Median and CMIC will leverage their complementary services to help biopharmaceutical companies accelerate oncology drug development in Japan, China and East Asia.   The agreement came following an onsite audit at Median’s headquarters in France late last year. Through the collaboration, CMIC will access Median’s innovative imaging technologies, services and ima...